Welcome to our dedicated page for Oxbridge Re Hldgs SEC filings (Ticker: OXBR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Oxbridge Re Holdings Limited (NASDAQ: OXBR) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, alongside AI-assisted summaries to help interpret complex documents. Oxbridge Re, a Cayman Islands-based reinsurer and issuer of tokenized Real-World Assets (RWAs), files reports with the U.S. Securities and Exchange Commission that detail its financial condition, reinsurance activities, and capital markets actions.
Investors can use this page to review annual reports on Form 10-K for a comprehensive discussion of risk factors, business operations, and consolidated financial statements, and quarterly reports on Form 10-Q for interim updates on net premiums earned, loss and expense ratios, combined ratios, restricted cash, and obligations to tokenholders. These filings reflect both the traditional property and casualty reinsurance segment and the tokenized reinsurance structures operated through SurancePlus Inc.
Current reports on Form 8-K document material events such as quarterly earnings announcements and capital raising activities. For example, an 8-K dated November 6, 2025 references a press release announcing financial results, while an 8-K dated September 16, 2025 describes a prospectus supplement to the company’s Form S-3 registration statement permitting sales of ordinary shares under an equity distribution agreement.
On Stock Titan, AI-powered tools can help users quickly identify key points within lengthy filings, such as changes in underwriting performance metrics, updates on catastrophe losses, or details of equity offerings. The filings page also surfaces insider and equity-related disclosures where available, enabling users to track how Oxbridge Re’s management and capital structure evolve over time.
By combining real-time EDGAR updates with concise AI explanations, this page helps investors, analysts, and researchers navigate Oxbridge Re’s regulatory history and better understand the company’s reinsurance and tokenized RWA activities.
Oxbridge Re Holdings Limited entered into a short-term financing agreement, borrowing
If the company defaults, the interest rate increases to 36% per year, or the maximum allowed by law. The loan can be repaid early without penalty, and is secured by a lien on substantially all of the company’s assets. Oxbridge Re plans to use the funds for working capital and general corporate purposes.
Oxbridge Re Holdings Limited announced that its indirect subsidiary SurancePlus Inc. has commenced a private offering of Participation Shares represented by digital tokens under a 3‑year Participation Share Investment Contract.
At launch, up to 2,000,000 Participation Shares labelled “T20‑2027” (balanced yield) and “T42‑2027” (high yield) will be offered at an initial price of $10.00 per Participation Share, with discounts of up to 5% for larger investments.
Net proceeds will be used by SurancePlus to purchase participating notes of affiliated reinsurer Oxbridge Re NS, whose note proceeds will be invested in collateralized reinsurance contracts. Holders are entitled to an Investor Final Return based on the initial price plus a share of net underwriting profits, with preferred return hurdles of 8% and 16% annualized for the balanced and high yield tranches, respectively.
The securities are being sold as unregistered offerings under SEC Rule 506(c) to accredited investors in the United States and under Regulation S to non‑U.S. persons, and this disclosure is furnished under Regulation FD rather than filed.
Oxbridge Re Holdings (OXBR) filed an 8-K stating it issued a press release announcing financial results for the quarter and nine months ended September 30, 2025. The release is furnished as Exhibit 99.1 under Item 2.02.
The company notes this information is furnished and not deemed “filed” under Section 18 of the Exchange Act. OXBR’s Ordinary Shares trade under OXBR and its warrants under OXBRW on The Nasdaq Capital Market.
Oxbridge Re (OXBR) reported Q3 2025 results with higher revenue but a smaller net loss. Total revenue was $645 thousand versus $205 thousand a year ago, driven by $555 thousand of net premiums earned and $79 thousand of net investment and other income. Expenses rose to $815 thousand from $498 thousand, and the net loss attributable to ordinary shareholders narrowed to $187 thousand (basic and diluted loss per share $0.02) from $540 thousand ($0.09) in Q3 2024.
For the nine months ended September 30, 2025, revenue increased to $2.0 million from $124 thousand, while total expenses were $5.0 million. The period included a $2.293 million reserve for losses related to Hurricane Milton; the filing states the net equity impact was $1.18 million after allocations to external tokenholders. Cash and restricted cash totaled $7.176 million at September 30, 2025, up from $5.893 million at year-end. Shareholders’ equity rose to $5.666 million from $4.110 million, supported by capital raises, including approximately $2.7 million net proceeds from a February 2025 offering and $873,515 net from ATM sales year-to-date.
Allan S. Martin, a director of Oxbridge Re Holdings Ltd (symbol: OXBRW), reported a sale of ordinary shares on 09/16/2025. The Form 4 shows 4,328 shares sold at $2.4505 per share, with the filing signed by an attorney-in-fact on 09/19/2025. Following the reported transaction, Mr. Martin directly holds 216,803 ordinary shares (jointly with his wife) and indirectly holds 68,770 shares via Fleur de Lis Partners, LLLP and 102,223 shares via the Martin Family Foundation, Inc., with disclaimers that he disclaims beneficial ownership of the indirectly held shares except to the extent of his pecuniary interest.
Oxbridge Re Holdings Limited filed a prospectus supplement allowing it to sell up to $2,021,889 of its ordinary shares under an existing equity distribution agreement with Maxim Group LLC. The company states it has already offered and sold $4.58 million of ordinary shares during the prior 12 months. As a result, $1,672,714 of capacity remains available to be sold pursuant to this prospectus supplement.
Oxbridge Re Holdings Limited is filing a prospectus supplement to register the offer and sale of up to $2,021,889 of its ordinary shares from time to time through Maxim Group LLC under an equity distribution (at-the-market) Sales Agreement. The company states that, under Form S-3 General Instruction I.B.6 limits and after selling approximately $4.58 million of securities in the prior 12 months, $1,672,714 of capacity remains available to be sold under this program. Its ordinary shares trade on the Nasdaq Capital Market under the symbol OXBR at a last reported price of $2.75 per share, with 7,635,922 ordinary shares outstanding as of September 15, 2025, of which 816,176 were held by affiliates.